Blood test aimed to speed up Alzheimer's diagnosis, but study was canceled
NCT ID NCT06856681
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to see if using a special blood test (PrecivityAD2) could help doctors diagnose Alzheimer's disease or other dementias more quickly. It was designed for veterans and people in other closed healthcare systems who had memory problems. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMERS DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data uncover hidden risks of the Alzheimer's drug LEQEMBI?
- Could a diabetes drug tame Alzheimer's inflammation?
- Nasal spray could tame brain inflammation in early Alzheimer's
- New drug aims to stop Alzheimer's before it starts in gene carriers
- Scientists hunt for molecular proof that music helps Alzheimer's patients
- Gum treatment may help fight Alzheimer's, small trial hints